Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 5
2005 8
2006 7
2007 14
2008 15
2009 14
2010 14
2011 13
2012 16
2013 17
2014 21
2015 20
2016 13
2017 16
2018 20
2019 14
2020 13
2021 15
2022 15
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Results by year

Filters applied: . Clear all
Page 1
Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment.
Dinh HQ, Pan F, Wang G, Huang QF, Olingy CE, Wu ZY, Wang SH, Xu X, Xu XE, He JZ, Yang Q, Orsulic S, Haro M, Li LY, Huang GW, Breunig JJ, Koeffler HP, Hedrick CC, Xu LY, Lin DC, Li EM. Dinh HQ, et al. Among authors: wu zy. Nat Commun. 2021 Dec 17;12(1):7335. doi: 10.1038/s41467-021-27599-5. Nat Commun. 2021. PMID: 34921160 Free PMC article.
Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting.
Liu W, Xie L, He YH, Wu ZY, Liu LX, Bai XF, Deng DX, Xu XE, Liao LD, Lin W, Heng JH, Xu X, Peng L, Huang QF, Li CY, Zhang ZD, Wang W, Zhang GR, Gao X, Wang SH, Li CQ, Xu LY, Liu W, Li EM. Liu W, et al. Among authors: wu zy. Nat Commun. 2021 Aug 16;12(1):4961. doi: 10.1038/s41467-021-25202-5. Nat Commun. 2021. PMID: 34400640 Free PMC article.
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open-label phase II trial.
Zhang L, Wu ZY, Li J, Lin Y, Liu Z, Cao Y, Zhang G, Gao HF, Yang M, Yang CQ, Zhu T, Cheng MY, Ji F, Li J, Wang K. Zhang L, et al. Among authors: wu zy. Int J Cancer. 2022 Feb 15;150(4):654-662. doi: 10.1002/ijc.33830. Epub 2021 Oct 7. Int J Cancer. 2022. PMID: 34591977 Free article. Clinical Trial.
N-[3-(Dimethyl-amino)-prop-yl]-N'-(2-hy-droxy-5-methyl-phen-yl)oxamide.
Zheng YJ, Zheng K, Wu ZY, Li Y. Zheng YJ, et al. Among authors: wu zy. Acta Crystallogr Sect E Struct Rep Online. 2012 Mar 1;68(Pt 3):o895. doi: 10.1107/S1600536812007957. Epub 2012 Feb 29. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22412744 Free PMC article.
2-(2-Eth-oxy-2-oxoacetamido)-benzoic acid.
Yu M, Wang L, Wang L, Wu Z. Yu M, et al. IUCrdata. 2020 May 6;5(Pt 5):x200603. doi: 10.1107/S2414314620006033. eCollection 2020 May. IUCrdata. 2020. PMID: 36337148 Free PMC article.
256 results